Number of Rotavirus (RV) Related Hospitalizations in Belgium - Season 2006-2007
NCT01563146 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1
Last updated 2018-03-12
Summary
This study aims to collect data and assess the number of rotavirus related hospitalizations in 11 hospitals in Belgium - season 2006-2007 in order to develop proper age-cohort analysis over time.
Conditions
- Infections, Rotavirus
Interventions
- OTHER
-
Data collection
Each participating centre will be requested to generate a coded list of all stool samples taken during the study period (June 1st 2006- May 31st 2007) and analysed for rotavirus, in children aged ≤5 years.
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
GSK Clinical Trials · GlaxoSmithKline
Eligibility
- Max Age
- 5 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-02-01
- Primary Completion
- 2017-12-31
- Completion
- 2017-12-31
More Related Trials
-
Surveillance Study to Estimate the Proportion of Rotavirus Gastroenteritis in Children < 5 Years of Age in Romania
NCT01253967 ·Status: COMPLETED
-
Vaccine Effectiveness of RV1 in a Naïve Population
NCT01467037 ·Status: COMPLETED
-
Surveillance of Rotavirus Gastroenteritis in Children <5 Years
NCT01363726 ·Status: UNKNOWN
-
Study to Assess the Impact of Vaccination on Hospitalizations and Outpatient Visits Due to Rotavirus Gastroenteritis
NCT01733862 ·Status: COMPLETED
-
Hospital-based Surveillance to Collect Prospective Data to Estimate the Disease Burden of Severe RV GE in Sweden
NCT00489567 ·Status: COMPLETED
-
Impact of Systematic Infants Vaccination Against Rotavirus on Gastroenteritis Hospitalization: a Prospective Study in Brest District, France.
NCT00740935 ·Status: COMPLETED ·Phase: PHASE4
-
Rotavirus Burden and Genotypes in a Sentinel Hospital Surveillance System in Lebanon
NCT01321216 ·Status: COMPLETED
-
Impact of Rotavirus Vaccination on Hospitalisations for Rotavirus Gastroenteritis in Children Aged <5 Years in Australia
NCT01236066 ·Status: COMPLETED
-
Impact of Rotavirus Vaccination on Hospital Pressures at a Large Paediatric Hospital in the UK: an Ecological Study
NCT03271593 ·Status: COMPLETED
-
Rotavirus Gastroenteritis and Vaccine Usage in Rhode Island
NCT01026779 ·Status: COMPLETED
-
Study to Evaluate the Effectiveness of Rotarix™ Against Severe Gastroenteritis Among Hospitalized Children in Brazil
NCT01177657 ·Status: COMPLETED
-
Effectiveness of Monovalent Rotavirus Vaccine (RV1)
NCT01871038 ·Status: COMPLETED
-
Canadian Rotavirus Surveillance Through the Immunization Monitoring Program Active (IMPACT)
NCT01633190 ·Status: UNKNOWN
-
Effectiveness of Rotarix™ Against Rotavirus Severe Gastroenteritis (RV SGE) in Infants in Panama
NCT00653198 ·Status: COMPLETED
-
Effectiveness of Human Rotavirus Vaccine, Rotarix™ Against Rotavirus Severe Gastroenteritis (RV SGE) in Infants
NCT00655187 ·Status: COMPLETED
-
The Efficacy of Three Doses of Live Attenuated, Oral Rotavirus Vaccine 116E
NCT05958771 ·Status: UNKNOWN ·Phase: PHASE3
-
The Epidemiology and Etiology of Acute Gastroenteritis Among Estonian Children After Introduction of Rotavirus Vaccines
NCT02662543 ·Status: UNKNOWN
-
Study to Analyze the Clinical and Cost Impact of Complete and Incomplete Rotavirus (RV) Vaccination
NCT01682005 ·Status: COMPLETED
-
Two-year Surveillance of Rotavirus Genotypes Causing Acute Diarrhea in Children Younger Than 5 Years Requiring Emergency Room (ER) and Hospital Admission in Chile
NCT00895492 ·Status: COMPLETED
-
Epidemiology of Rotavirus Infection in North India Community
NCT01508533 ·Status: COMPLETED
-
Improving Rotavirus Vaccine Immune Response
NCT01825109 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness of RotarixTM Vaccine in Children Aged Between 12 Weeks to < 5 Years, Hospitalised for Severe Gastroenteritis
NCT01978223 ·Status: WITHDRAWN
-
The Efficacy of Oral Rotavirus Vaccine 116E (ROTAVAC 5D) in Chilean Infants
NCT06200844 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Human Challenge With Live-attenuated Rotavirus to Assess Next-generation Rotavirus Vaccines in Africa
NCT04658914 ·Status: COMPLETED ·Phase: PHASE2
-
ROTATEQ Reexamination Study (V260-037)
NCT01074242 ·Status: COMPLETED